Clinical Trial Update: A Study Using The Experimental Drug Called Imatinib (Gleevec) in Subjects With Systemic Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

This update covers a Phase 1/2 trial of Imatinib (Gleevec) in systemic sclerosis and alveolitis, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolitis
• Systemic Sclerosis

Drugs mentioned

• Gleevec (imatinib) (imatinib)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Alveolitis, Systemic Sclerosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-10-27